Study on tumor active targeting with Transferrin-PEG-PAMAM dendrimer-CPT conjugate

Tang Guotao,Zhu Saijie,Hong Minghuang,Jiang Yanyan,Pei Yuanying
DOI: https://doi.org/10.3969/j.issn.2095-1264.2012.02.005
2012-01-01
Abstract:Objective To explore the pharmacokinetics characteristic of transferrin modified PEG ylated polyamidoamine dendrimers(PEG-PAMAM) as the carrier for tumor targeting of the anticancer drug camptothecin(CPT) in rats.Methods CPT solution and PEG-PAMAM-CPT were used as control,transferrin modified PEG-PAMAM-CPT was injected via the tail vein.The plasma concentration of CPT in rats was determined by HPLC following alkaline hydrolysis.Results Transferrin modified PAMAM-PEG-CPT could enhance half-life and mean residence time comparing with that of CPT solution,but were relative shorter than that of CPT-PAMAM-PEG.Conclusion Transferrin modified PAMAM-PEG-CPT had a better long-circulating effect in rats.
What problem does this paper attempt to address?